Clinical

Clinical  ·  Weekly Digest 1 to 6 Sep 2024
AstraZeneca drives progress in enhancing cancer care standards across multiple cancer types at WCLC and ESMO 2024

Weekly Digest – September 2024 Weekly Digest – September 2024 3 Sep 2024: AstraZeneca drives progress in enhancing cancer care standards across multiple cancer types at WCLC and ESMO 2024 AstraZeneca will present new data at the IASLC 2024 World […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest 1 to 6 Sep 2024
Daiichi Sankyo showcases new breakthroughs in its leading ADC portfolio for multiple cancers at WCLC and ESMO

Weekly Digest – September 2024 Weekly Digest – September 2024 27 Aug 2024: Mabwell receives approval for Phase III trial of urothelial carcinoma drug in China Mabwell Therapeutics has received approval from NMPA to begin a Phase III clinical trial […]

by Sandhya Ramalingam

Continue Reading